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Dental and maxillomandibular 
incidental findings in panoramic 
radiography among individuals with 
mucopolysaccharidosis: a cross-
sectional study
Mucopolysaccharidosis (MPS) is a group of rare and inherited metabolic 
disorders caused by the accumulation of macromolecule glycosaminoglycans 
inside lysosomes. Affected individuals may have dental and craniofacial 
tissue alterations, facilitating the development of several oral diseases. 
Objectives: To assess, with panoramic radiographic images, the frequency 
of dental and maxillomandibular incidental findings among MPS individuals 
and compare them with non-MPS individuals. Methodology: A cross-
sectional study evaluating a sample of 14 MPS individuals and 28 non-MPS 
individuals aged from 5 to 26 years was carried out. They were matched 
for sex and age on a 2:1 proportion. Panoramic radiographs were assessed 
for the presence/absence of the following dental and maxillomandibular 
alterations: dental anomalies of number (hypodontia/dental agenesis, 
supernumerary teeth); anomalies of form (microdontia, macrodontia, 
conoid teeth, taurodontism, and root dilaceration); anomalies of position 
(impacted tooth, inverted tooth, tooth migration, partially bony teeth, 
complete bony teeth); periapical alterations (furcation lesion, circumscribed 
bone rarefaction); other alterations (radiolucent bone lesions, radiopaque 
bone lesions, radiopacity in the maxillary sinus, condylar hypoplasia). 
Differences between groups were tested by the Fisher’s exact test and chi-
square test (p<0.05). Results: For intrarater agreement, Kappa values were 
0.76 to 0.85. The presence of supernumerary teeth (p=0.003); conoid teeth 
(p=0.009); taurodontism (p<0.001); impacted teeth (p<0.001); partial 
bony teeth (p=0.040); complete bony teeth (p=0.013); and root dilaceration 
(p=0.047) were statistically more frequent in MPS individuals compared to 
non-MPS individuals. Bone rarefaction/furcation lesions (p=0.032), condylar 
hypoplasia (p<0.001), radiolucent bone lesions (p=0.001), and dentigerous 
cysts (p=0.002) were also more frequent in MPS individuals. Conclusion: The 
presence of specific oral manifestations is more common in MPS individuals 
than non-MPS individuals. 
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Introduction
Mucopolysaccharidosis (MPS) are a group of 
inherited lysosomal storage diseases occurring due 
to a deficiency in some enzymes responsible for 
glycosaminoglycans (GAGs) degradation. The non-
degradation of GAGs leads to their accumulation in 
cells and tissues, causing progressive accumulation 
and cell dysfunction.1 There are seven types of MPS (I, 
II, III, IV, VI, VII, and IX), and the literature describes 
the overall prevalence of MPS ranging from 1.04 to 
4.8/100.000 births.2
The nature of MPS is progressive, leading to several 
systemic manifestations that vary according to type 
and severity of the diseases. The most common 
systemic features observed in MPS individuals are 
the presence of inguinal and umbilical hernias, upper 
respiratory infections, corneal clouding, skeletal 
dysplasia, growth impairment, limited joint motion, 
and behavioral anomalies.3,4  
Oral and craniofacial manifestations are also 
frequent in MPS individuals. The literature describes 
the presence of macroglossia, malocclusion traits (i.e., 
anterior open bite), delayed tooth eruption, cystic 
lesions, and condylar defects in individuals with MPS 
as typical.5-8 MPS individuals are also a group with 
a higher vulnerability to dental caries, therefore, 
requiring better guidance and access to preventive 
oral health programs.9,10 
It has been stated in the literature that the presence 
of dental and/or maxillomandibular anomalies can 
be considered a hampering factor for some dental 
treatments, such as root canal therapy, or it may 
also cause pain, sensitivity or aesthetic problems to 
patients.11 Therefore, identifying such problems, mainly 
in individuals with disabilities, can minimize associated 
clinical consequences and enhance patients’ quality 
of life. Regarding to analyses of oral manifestations 
in individuals with MPS, there are few studies with 
adequate methodological quality. Most studies are case 
series that do not have a comparison group to provide 
clinicians with information on what they might expect 
when dealing with MPS individuals.5-8 
Thus, this study evaluates, based on panoramic 
radiographic images, the frequency of dental 
and maxillomandibular incidental findings among 
individuals with MPS and comparing them with 
matched non-MPS individuals.
Methodology
This article is in accordance with The Strengthening 
the Reporting of Observational Studies in Epidemiology 
(STROBE) statement.12 
The Research Ethics Committee of the Universidade 
Federal de Minas Gerais approved this article (protocol 
No. 01480212.4.0000.5149). Parents/caregivers and 
individuals with and without MPS willing to participate 
voluntarily signed an informed permission or consent 
form.
A cross-sectional study was carried out with a 
sample of MPS individuals aged from 5 to 26 years 
matched with non-MPS individuals. MPS individuals 
were selected in two hospitals (Southeastern Brazil). 
There were 29 MPS individuals registered at the two 
hospitals. These individuals were assessed regarding 
eligibility. These hospitals are referral centers for the 
care of individuals with such condition. MPS can be 
classified in MPS type I, II, III, IV, VI, VII, and IX2 and 
its classification is carried out with laboratory exams, 
according to the enzyme involved in the degradation 
pathway of a specific GAG. In this study, the type of 
MPS was recorded by mother’s knowledge of a full 
diagnosis.
Non-MPS individuals were selected in the outpatient 
clinics of the same two hospitals. They were individuals 
without any systemic conditions or syndromes, just 
applying for an annual health care visit. MPS and non-
MPS individuals were individually matched for sex and 
age on a 2:1 ratio. Individuals with previous orthodontic 
treatment history and those with uncooperative 
behavior during the radiographic examination were 
excluded from the study. Data collection occurred from 
January/2015 to December/2017.
Panoramic radiographic examination was performed 
as part of a comprehensive oral review. Presence or 
absence of the following dental and maxillomandibular 
alterations were considered in that examination:13 
dental anomalies of number (hypodontia/dental 
agenesis, supernumerary teeth); anomalies of form 
(microdontia, macrodontia, conoid teeth, taurodontism 
and root dilaceration); anomalies of position (impacted 
teeth, inverted teeth, tooth migration, partial bony 
teeth, complete bony teeth); periapical alterations 
(furcation lesion, circumscribed bone rarefaction); 
other alterations (radiolucent bone lesions, radiopaque 
bone lesions, radiopacity in the maxillary sinus, 
condylar hypoplasia). 
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A single-blinded radiologist with over 10 years 
of experience performed the interpretation of the 
panoramic radiographs. The rater was previously 
calibrated for data collection. The panoramic 
radiographs of 15 non-MPS individuals were examined, 
for the calibration process. They were re-examined two 
weeks later for the intra-rater agreement estimation. 
Those radiographs were not included in the main study. 
Before the main study, a pilot study was also 
performed. The sample was composed of five 
MPS individuals and five non-MPS individuals. The 
results indicated that changes in the methodological 
procedures were deemed unnecessary.
Data analyses were conducted using the Statistical 
Package for Social Sciences (SPSS for Windows, 
version 21.0, SPSS IBM Corp., Armonk, N.Y., USA). 
Descriptive and bivariate analyses were carried out. 
The Fisher’s exact test and chi-square (X²) test were 
used to compare MPS and non-MPS participants 
concerning the panoramic radiographic findings 
(p<0.05). 
Results
For the intra-rater agreement, Kappa values 
obtained ranging from 0.76 to 0.85 were very good.14 
Among the 29 MPS individuals who were assessed 
regarding eligibility, 14 were included and evaluated. 
Figure 1- Panoramic radiographs of patients with MPS type VI, aged 19 (A) and 18 (B) years old, showing the presence of extensive 
maxillomandibular alterations
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In total, 15 MPS individuals were excluded due to 
the advanced conditions of their disease – that 
made proper head positioning unfeasible – lack 
of cooperation during examinations, and previous 
orthodontic treatment. The final sample comprised 
42 individuals (14 with MPS and 28 without MPS) 
matched for age and sex. Most participants were 
male individuals (57.1%). The mean age of the 42 
individuals was 13.9 years (±7.2).
Regarding the type of MPS, the individuals were 
classified as follows: MPS I (n=4), MPS II (n=2), MPS 
IV (n=1) and MPS VI (n=7). No individuals with MPS 
type III and IX were identified. Figure 1 and Figure 2 
shows the panoramic radiographs of individuals with 
Figure 2- Panoramic radiographs of individuals with MPS type VI, aged 18 years old (A) and MPS type I, aged 6 years old (B), showing 
taurodontism, root dilaceration, tooth agenesis, and tooth impaction
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MPS and some identified dental alterations in the 
maxilla and mandible.
Table 1 shows the results of the comparison 
between MPS and non-MPS individuals concerning the 
presence of dental anomalies observed in panoramic 
radiographs. Some alterations were statistically more 
prevalent in MPS individuals compared to non-MPS 
individuals: supernumerary teeth (p=0.003); conoid 
teeth (p=0.009); taurodontism (p<0.001); impacted 
teeth (p<0.001); partial bony teeth (p=0.040); 
complete bony teeth (p=0.013); and root dilaceration 
(p=0.047)
Table 2 shows the comparative analysis of the 
frequency of maxillomandibular alterations observed 
GROUP
Dental abnormalities MPS individuals Non-MPS individuals Odds ratio 
(Confidence Interval) p Value
n (%) n (%)
ANOMALIES OF NUMBER
Hypodontia (Dental Agenesis)
0.647aPresence 4 (28.6) 8 (28.6) 1.00 [0.24-4.13]
Absence 10 (71.4) 20 (71.4)
Supernumerary teeth
0.003aPresence 7 (50.0) 2 (7.1) 3.66 [1.74-7.72]
Absence 7 (50.0) 26 (92.9)
ANOMALIES OF FORM
Microdontia
0.100aPresence 3 (21.4) 1 (3.6) 7.36 [0.68-78.71]
Absence 11 (78.6) 27 (96.4)
Conoid teeth 
0.009aPresence 4 (28.6) 0 3.80 [2.32-6.46]
Absence 10 (71.4) 28 (100)
Taurodontism
<0.001aPresence 8 (57.1) 1 (3.6) 4.88 [2.28-10.45]
Absence 6 (42.9) 27 (96.4)
ANOMALIES OF POSITION
Impacted Teeth
<0.001aPresence 11 (78.6) 6 (21.4) 13.44 [2.81-64.20]
Absence 3 (21.4) 22 (78.6)
Inverted teeth
0.333aPresence 1 (7.1) 0 3.15 [2.01-4.94]
Absence 13 (92.9) 28 (100)
Migration
Presence      1 (7.1) 0
0.500a
Absence 13 (92.9) 28 (100) 3.15 [2.01-4.94]
Partial bony teeth
0.040bPresence 8 (57.1) 7 (46.7) 4.00 [1.02-15.59]
Absence 6 (42.9) 21 (75)
Complete bony teeth
0.013bPresence 9 (64.3) 7(25.0) 5.4 [1.34-21.63]




Presence 9 (64.3) 9 (31.1) 3.8 [1.02-14.66]
aFisher’s exact test/ b Pearson Chi Square (5% significance level)
Table 1- Comparative radiographic analysis of the presence of dental anomalies between MPS and non-MPS individuals (n=42)
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among MPS and non-MPS individuals. The prevalence 
of bone rarefaction/furcation lesions (p=0.032) and 
condylar hypoplasia (p<0.001) were significantly 
more frequent in MPS individuals. Regarding other 
maxillomandibular alterations, the presence of 
radiolucent bone lesions (p=0.001), dentigerous cysts 
(p=0.002) was also more frequent in MPS individuals. 
The presence of condylar hypoplasia was also observed 
in all MPS individuals, whereas in only one non-MPS 
individual, this alteration was observed (p<0.001).
Discussion
The presence of dental and maxillomandibular 
alterations can have far-reaching effects on an 
individual’s quality of life, causing pain, increased 
sensitivity, and esthetic issues.11 Significant differences 
between MPS and non-MPS individuals regarding 
radiographic findings were observed. MPS individuals 
presented higher frequencies of incidental findings. 
MPS individuals face several systemic alterations 
during the disease progression. Those alterations have 
been described in the literature, and the management 
guidelines have been reported.15 However, due to the 
rarity of the disease regarding dental alterations, there 
is a lack of in-depth knowledge concerning dental 
alterations among oral health practitioners.
Identification of oral manifestations in MPS 
individuals can help clinicians diagnose dental diseases 
earlier and also better support dental treatment 
planning. This process may minimize possible 
complications that could affect those individuals. 
Radical examinations, such as panoramic radiographs, 
are still considered a significant dental screening 
tool. Radiographic equipment is easy to use, provides 
cost-effective low-dose radiation, and it is used in 
epidemiological studies to evaluate the presence of 
dental and maxillomandibular anomalies.16 
Among dental abnormalities, the most relevant 
radiographic manifestations found in MPS individuals 
compared to non-MPS individuals were supernumerary 
tooth, conoid teeth, taurodontism, and impacted 
GROUP
Maxillomandibular  alterations MPS individuals Non-MPS individuals Odds [Confidence 
Interval] P Value
n (%) n (%)
PERIAPICAL ALTERATIONS
Bone rarefaction (furcation lesions)
0.032aPresence 3 (21.4) 0 3.54 [2.14-5.85]
Absence 11 (78.6) 28 (100)
Circumscribed bone rarefaction
0.333aPresence 1 (7.1) 0 3.15 [2.01-4.94]
Absence 13 (92.9) 28 (100)
OTHER
Radiolucent bone lesions
0.001aPresence 9 (64.3) 3 (10.7) 15.00 [2.96-75.91]
Absence 5 (35.7) 25 (89.3)
Diagnostic hypothesis for radiolucent bone 
lesions
Dentigerous cyst 8 (57.1) 3 (10.7) 11.11 [2.24-54.94]
0.002a
Absence 6 (42.9) 25 (89.3)
Radiopacity in the maxillary sinus
0.374bPresence 7 (50.0) 10 (35.7) 1.80 [0.49-6.61]
Absence 7 (50.0) 18 (64.3)
Condylar Hypoplasia
<0.001aPresence 14 (100) 1 (3.6) 0.06 [0.01-0.44]
Absence 0 27 (96.4)
aFisher’s exact test/ bPearson Chi Square/ (5% significance level)
Table 2- Comparative radiographic analysis of the presence of maxillomandibular alterations between MPS and non-MPS individuals 
(N=42)
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teeth (partially and/or completed bony), and root 
dilaceration. The presence of dental abnormalities can 
lead to some issues in the function and development 
of the stomatognathic system, such as a delayed 
transition from deciduous to permanent dentition, 
impairment of occlusion, altered chewing and aesthetic 
issues. In a group of individuals already facing 
systemic disabilities, early identification and timely 
management of dental anomalies are recommended. 
The findings of previous studies corroborate our 
results as they showed that dental anomalies are highly 
frequent among MPS individuals. Almeida-Barros, et 
al.6 (2018), identified the presence of supernumerary 
teeth in 23.5% of the 17 MPS individuals evaluated 
(only MPS type IV and VI). The literature also indicates 
that the frequency of taurodontism and impacted 
teeth is higher among MPS individuals. According to 
Sarmento, et al.17 (2015), 68.7% of the evaluated MPS 
individuals presented both alterations. Kantaputra, et 
al.18 (2013), showed that 53.8% of their sample had 
taurodontism.
The literature suggests that the constant 
accumulation of GAGs in cells is the main factor 
involved in developing orofacial alterations in MPS 
individuals. However, the extent and significance of 
this process are still uncertain.19,20 Oussoren, et al.21 
(2011) described that GAGs might interfere with 
the regulatory process of growth using the function 
of bone morphogenetic proteins alteration. These 
proteins are multi-functional growth factors belonging 
to the transforming growth factor β superfamily. 
Consequently, the interaction of GAGs in the growth 
pathway can lead to tooth cytodifferentiation and 
supporting periodontal tissue defects.
Panoramic radiographs also revealed furcation 
lesions and radiolucent bone lesions (with 57.1% 
of likely dentigerous cysts) were the most frequent 
maxillomandibular alterations observed in most MPS 
individuals compared to their non-MPS peers. Other 
studies showed that dentigerous cysts are highly 
frequent in MPS individuals. Sarmento, et al.17 (2015) 
observed a 75.0% frequency of dentigerous cysts 
occurrence. Ballikaya, et al.7 (2018) observed that 
83.3% of the 12 MPS individuals examined also had 
enlarged dental follicles. The cystic transformation 
of the dental follicle in MPS individuals may also be 
associated with GAGs accumulation.
In the present study, the authors suggest 
diagnosing dentigerous cysts in the studied sample 
due to the presence of a well-circumscribed, unilocular 
radiolucency around the crown of an impacted or 
developing tooth, with their largest dimension ranging 
from 2.0 cm to 4.0 cm of diameter. However, to confirm 
a cystic lesion presence, complementary examinations, 
such as three-dimensional (3D) computed tomography 
(CT), biopsy, and cytopathologic analysis are 
recommended.22-24  
Generally, dentigerous cysts are asymptomatic 
and they are usually diagnosed during routine dental 
care. However, they can become large in some cases, 
leading to tooth malposition or even causing tooth 
and bone resorption. The most frequently suggested 
treatment is the complete surgical enucleation and 
extraction of the associated impacted tooth or, in 
some cases, decompression or marsupialization in a 
developing tooth.25 
Due to some physical or mental impairment 
inherent to MPS disease, clinicians may face some 
difficulties in conducting regular dental treatment in 
these individuals. In some cases, general anesthesia 
– to perform dental surgical procedures – may be 
necessary. However, dental practitioners should be 
aware that airway problems are common in MPS 
individuals, and the risks imposed during perioperative 
intubation should be considered. Therefore, in 
individuals with MPS, preventive and conservative 
dental treatments should be a priority to avoid some 
possible systemic injuries.26.27 
In this study, increased condylar hypoplasia 
prevalence was observed among all MPS individuals 
compared to non-MPS individuals. One of the most 
explicit characteristics of MPS is limited joint mobility 
and ligamentous laxity due to the involvement of GAGs 
throughout the ligaments and joint capsules. The 
constant accumulation of GAGs in those regions can, 
consequently, lead to joint degeneration.4 Using CT 
views and 3D images, Torres et al. (2018) compared, 
in a case report, the mandibles of one MPS individual 
and one non-MPS patient. The authors observed the 
presence of higher coronoid process and condylar 
hypoplasia in the mandible of MPS individual, and this 
finding correlates with our observations.28 
The progressive resorption of condyles may lead 
to several consequences for MPS individuals. Those 
alterations might provoke issues in articulating 
the mandible, resulting in an open bite as well as 
mandibular and facial asymmetry. Another factor 
is the condylar hypoplasia, which may also hinder 
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the dental treatment, as some MPS patients can 
develop limitations on mouth opening. According to 
Chouinard, Kaban, Peacock29 (2018), it is important 
to perform an early diagnosis of temporomandibular 
joint abnormalities to determine the progression of 
the deformities, predict the prognosis, and plan an 
adequate treatment plan.29 
In our study, it was impossible to carry out a 
complete analysis evaluating differences among 
individuals with different type of MPS regarding 
oral conditions, because of the low number of MPS 
individuals in each subgroup. Although systemic 
differences have been well recognized in the literature,3 
the extent and significance of the differences among 
all MPS types concerning oral manifestations are still 
scarce. Most MPS individuals included in this study 
belonged to the group of MPS VI. MPS VI is described 
as the type that presents the most severe skeletal 
phenotype, although individuals usually do not have 
their neurological functions affected.1 Few studies 
have performed subgroup analyses to evaluate 
differences between MPS types. Yet, these studies 
have failed to compare all MPS types simultaneously 
due to the disease rare nature. Turra, Schwartz30 
(2009) compared the differences among individuals 
with MPS types I, II, and VI regarding the structure 
of the stomatognathic system. Significant difference 
was found only for the position of the tongue between 
teeth. This outcome was more frequent in MPS VI. 
Sarmento, et al.17 (2015) evaluated MPS types I, IV, 
and VI and showed that all individuals with MPS type 
VI presented enlarged, cyst-like dental crypt. The 
presence of impacted tooth was also higher among 
individuals with MPS type VI.
Although previous studies have determined 
the presence of dental and/or maxillomandibular 
anomalies among MPS individuals, those studies were 
case series or cross-sectional studies with limited 
sample sizes that could not support strong statistical 
inferences. The presence of dental/maxillomandibular 
anomalies in MPS individuals cannot be defined or be 
associated with a severe or attenuated form of MPS, 
but the findings of our study can contribute to clinical 
practice with a better understanding of the clinical 
consequences that might be inherent in this rare 
disease. Some surgical interventions or orthodontic 
treatment might be necessary to correct or to minimize 
dental problems, and the clinicians must be aware of 
how to perform therapeutic interventions, considering 
the systemic and physical limitations that these 
individuals might present.
Some limitations of this study should be highlighted. 
The first is inherent to the design of a cross-sectional 
study. The results presented cannot be used to assess 
causality. They suggested an increased prevalence of 
dental alterations among MPS individuals. Secondly, 
a qualitative assessment of the presence and absence 
of dentofacial anomalies was performed. The authors 
suggest that future studies quantifying the extent 
of those alterations should be performed. Two-
dimensional panoramic radiographs were used to 
measure dental and maxillomandibular alterations, 
and it is known that these exams present geometric 
distortion and structural superimposition. However, 
this study can be considered a starting point for 
future epidemiological studies regarding dental and 
maxillomandibular features in MPS individuals using 
a 3D tool. Finally, it is noteworthy that sample size 
should not be considered a major limitation as MPS 
has a relatively low overall prevalence, making large 
sample recruitment quite challenging.
Conclusion
MPS individuals showed an increased frequency 
of dental and maxillomandibular incidental findings 
when compared to non-MPS individuals. The increased 
presence of supernumerary teeth, conoid teeth, 
taurodontism, impacted teeth, and root dilaceration 
was observed. The presence of bone rarefaction/
furcation lesions, condylar hypoplasia, and radiolucent 
bone lesions were also more frequent among MPS 
individuals.
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